112 related articles for article (PubMed ID: 36640595)
1. Design, synthesis and biological evaluation of novel 9-N-substituted-13-alkylberberine derivatives from Chinese medicine as anti-hepatocellular carcinoma agents.
Chen J; Duan Y; Yang K; Wang J; Yan J; Gu C; Wang S; Zhu Z; Liu EH; Xu J
Bioorg Med Chem; 2023 Feb; 79():117156. PubMed ID: 36640595
[TBL] [Abstract][Full Text] [Related]
2. Development of novel 9-
Chen J; Duan Y; Yu X; Zhong J; Bai J; Li NG; Zhu Z; Xu J
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2423-2433. PubMed ID: 36065941
[TBL] [Abstract][Full Text] [Related]
3. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway.
Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL
Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533
[TBL] [Abstract][Full Text] [Related]
4. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
[TBL] [Abstract][Full Text] [Related]
5. Lappaconitine Sulfate Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Reactive Oxygen Species-Dependent Mitochondrial Pathway.
Zhang X; Ma J; Song N; Guo Y; Hui L; Sang C
Pharmacology; 2020; 105(11-12):705-714. PubMed ID: 32062649
[TBL] [Abstract][Full Text] [Related]
6. Alpinia oxyphylla oil induces apoptosis of hepatocellular carcinoma cells via PI3K/Akt pathway in vitro and in vivo.
Hui F; Qin X; Zhang Q; Li R; Liu M; Ren T; Zhao M; Zhao Q
Biomed Pharmacother; 2019 Jan; 109():2365-2374. PubMed ID: 30551496
[TBL] [Abstract][Full Text] [Related]
7. Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways.
Zhang H; Li JC; Luo H; Zhao L; Zhang ZD; Shen XF
Phytomedicine; 2019 Jun; 59():152759. PubMed ID: 31004883
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Evaluation of Novel Quinazolinone Derivatives as Potential Anti-HCC Agents.
Qiu J; Zou Y; Liu Q; Jiang C; Zhou Q; Li S; Chen W; Li Z; Gu X
Chem Biodivers; 2022 Feb; 19(2):e202100766. PubMed ID: 34862731
[TBL] [Abstract][Full Text] [Related]
9. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory Effect of Hernandezine on the Proliferation of Hepatocellular Carcinoma.
Kuok C; Wang Q; Fong P; Qin Y; Meng L
Biol Pharm Bull; 2023; 46(2):245-256. PubMed ID: 36724952
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of novel 7-ethyl-10-fluoro-20-O-(cinnamic acid ester)-camptothecin derivatives as potential high selectivity and low toxicity topoisomerase I inhibitors for hepatocellular carcinoma.
Bai YP; Yang CJ; Deng N; Zhang M; Zhang ZJ; Li L; Zhou Y; Luo XF; Xu CR; Zhang BQ; Ma Y; Liu YQ
Biochem Pharmacol; 2022 Jun; 200():115049. PubMed ID: 35469784
[TBL] [Abstract][Full Text] [Related]
12. Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.
Singh AR; Joshi S; Burgoyne AM; Sicklick JK; Ikeda S; Kono Y; Garlich JR; Morales GA; Durden DL
Mol Cancer Ther; 2016 Nov; 15(11):2553-2562. PubMed ID: 27496136
[TBL] [Abstract][Full Text] [Related]
13. LINC01133 aggravates the progression of hepatocellular carcinoma by activating the PI3K/AKT pathway.
Zheng YF; Zhang XY; Bu YZ
J Cell Biochem; 2019 Mar; 120(3):4172-4179. PubMed ID: 30548306
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of artemyrianolide H derivatives as potential antihepatoma agents.
Li TZ; Yang XT; Ma WJ; Ma YB; Li FJ; Wang YC; Chen JJ
Bioorg Chem; 2023 Aug; 137():106617. PubMed ID: 37267793
[TBL] [Abstract][Full Text] [Related]
15. Molecular docking, anti-proliferative activity and induction of apoptosis in human liver cancer cells treated with androstane derivatives: Implication of PI3K/AKT/mTOR pathway.
Kattan SW; Nafie MS; Elmgeed GA; Alelwani W; Badar M; Tantawy MA
J Steroid Biochem Mol Biol; 2020 Apr; 198():105604. PubMed ID: 31982513
[TBL] [Abstract][Full Text] [Related]
16. The antiproliferative effect of spectinabilins from Streptomyces spectabilis on hepatocellular carcinoma cells in vitro and in vivo.
Gao X; Yao H; Mu Y; Guan P; Li G; Lin B; Jiang Y; Han L; Huang X; Jiang C
Bioorg Chem; 2019 Dec; 93():103311. PubMed ID: 31586709
[TBL] [Abstract][Full Text] [Related]
17. Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis.
Zhang DM; Liu JS; Tang MK; Yiu A; Cao HH; Jiang L; Chan JY; Tian HY; Fung KP; Ye WC
Eur J Pharmacol; 2012 Oct; 692(1-3):19-28. PubMed ID: 22841670
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel nitric oxide-donating protoberberine derivatives as antitumor agents.
Chen J; Wang T; Xu S; Lin A; Yao H; Xie W; Zhu Z; Xu J
Eur J Med Chem; 2017 May; 132():173-183. PubMed ID: 28359045
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
[TBL] [Abstract][Full Text] [Related]
20. Itraconazole exerts anti-liver cancer potential through the Wnt, PI3K/AKT/mTOR, and ROS pathways.
Wang W; Dong X; Liu Y; Ni B; Sai N; You L; Sun M; Yao Y; Qu C; Yin X; Ni J
Biomed Pharmacother; 2020 Nov; 131():110661. PubMed ID: 32942154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]